PrediLife Institut Curie partner for new test predicting breast cancer risk

PrediLife, Institut Curie partner for new test predicting breast cancer risk

07:45 EDT 7 May 2019 | Compelo Medical Devices

PrediLife said that the new generation of its MammoRisk predictive test incorporates a polygenic score based on a saliva sample of the patients. Breast cancer is identified to

More From BioPortfolio on "PrediLife, Institut Curie partner for new test predicting breast cancer risk"